180 Life Sciences Corp. (ATNF) is a publicly traded company in the Unknown sector. Across all available filings, 14 corporate insiders have executed 70 transactions totaling $1.0M, demonstrating a bullish sentiment with $173.0K in net insider flow. The most recent transaction on Jul 7, 2025 involved a transaction of 160,000 shares valued at $0.
No significant insider buying has been recorded for ATNF in the recent period.
No significant insider selling has been recorded for ATNF in the recent period.
Based on recent SEC filings, insider sentiment for ATNF is bullish with an Insider Alignment Score of 58/100 and a net flow of $173.0K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at 180 Life Sciences Corp. (ATNF) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 14 insiders are actively trading ATNF stock, having executed 70 transactions in the past 90 days. The most active insider is Marc Feldmann (Executive), who has made 6 transactions totaling $1.2M.
Get notified when executives and directors at ATNF file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jul 7, 2025 | Jordan Blair | Executive | Other | 160,000 | $N/A | $0 | |
| Jul 7, 2025 | Jordan Blair | Executive | Other | 160,000 | $N/A | $0 | |
| Dec 28, 2023 | Feldmann Marc | Executive | Award | 135,377 | $N/A | $0 | |
| Dec 15, 2023 | Feldmann Marc | Executive | Sale | 25,000 | $0.19 | $4.8K | |
| Dec 15, 2023 | N. Woody James | Executive | Purchase | 25,000 | $0.19 | $4.8K | |
| Sep 4, 2023 | G. Marrone Pamela | Executive | Award | 22,388 | $N/A | $0 | |
| Sep 4, 2023 | Donald A. Mcgovern Jr. | Executive | Award | 25,186 | $N/A | $0 | |
| Sep 4, 2023 | Marshall Gold Lawrence | Executive | Award | 21,455 | $N/A | $0 | |
| Sep 4, 2023 | T. Ray Russell | Executive | Award | 21,455 | $1.36 | $29.2K | |
| Jun 1, 2023 | Steinman Lawrence | Executive | Purchase | 18,000 | $1.23 | $22.1K | |
| May 31, 2023 | Donald A. Mcgovern Jr. | Executive | Purchase | 10,000 | $1.15 | $11.5K | |
| May 19, 2023 | Donald A. Mcgovern Jr. | Executive | Purchase | 5,000 | $1.16 | $5.8K | |
| May 18, 2023 | N. Woody James | Executive | Purchase | 40,000 | $1.03 | $41.2K | |
| May 18, 2023 | Pamir Ozan | Executive | Purchase | 5,162.08 | $1.01 | $5.2K | |
| May 18, 2023 | G. Marrone Pamela | Executive | Purchase | 7,082.02 | $1.06 | $7.5K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Award(A) | 32 | $1.5M | 45.5% |
Conversion(C) | 2 | $795.0K | 23.5% |
Purchase(P) | 21 | $611.4K | 18.1% |
Sale(S) | 10 | $438.4K | 13.0% |
Other(J) | 5 | $0 | 0.0% |
Insider activity at 180 Life Sciences Corp. shows mixed signals across all time. While $611.4K in purchases indicates some executive confidence,$438.4K in sales balances the picture, resulting in a modest net flow of $173.0K.14 insiders have been active, with no strong directional conviction evident in the aggregate data. The most active insider, Marc Feldmann, has transacted $1.2M during this period.